These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 19373300

  • 1. [Irreversible, non-selective monoamine oxidase inhibitors].
    Castberg I, Spigset O.
    Tidsskr Nor Laegeforen; 2009 Apr 16; 129(8):746-8. PubMed ID: 19373300
    [Abstract] [Full Text] [Related]

  • 2. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA.
    Ned Tijdschr Geneeskd; 2003 Oct 04; 147(40):1940-3. PubMed ID: 14574774
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T, Iwamoto N, Kitaichi Y, Kato A, Inoue T, Koyama T.
    Eur J Pharmacol; 2007 Jun 22; 565(1-3):105-12. PubMed ID: 17400208
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MAOIs and Ménière's syndrome.
    Mattes JA.
    Am J Psychiatry; 1990 Apr 22; 147(4):534. PubMed ID: 2316744
    [No Abstract] [Full Text] [Related]

  • 7. Not all monoamine oxidase inhibitors are created equal.
    Stewart JT.
    J Am Geriatr Soc; 2007 Nov 22; 55(11):1890. PubMed ID: 17979910
    [No Abstract] [Full Text] [Related]

  • 8. Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome.
    Rim CL, Gitlin MJ.
    J Clin Psychopharmacol; 2010 Aug 22; 30(4):470-1. PubMed ID: 20631570
    [No Abstract] [Full Text] [Related]

  • 9. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP, Gleiter CH, Möller HJ.
    Nervenarzt; 1996 May 22; 67(5):339-47. PubMed ID: 9005342
    [Abstract] [Full Text] [Related]

  • 10. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update.
    Flockhart DA.
    J Clin Psychiatry; 2012 May 22; 73 Suppl 1():17-24. PubMed ID: 22951238
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A neglected modality in psychiatric treatment--the monoamine oxidase inhibitors.
    Johnson WC.
    Dis Nerv Syst; 1975 Sep 22; 36(9):521-5. PubMed ID: 1175468
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
    Adli M, Pilhatsch M, Bauer M, Köberle U, Ricken R, Janssen G, Ulrich S, Bschor T.
    Pharmacopsychiatry; 2008 Nov 22; 41(6):252-7. PubMed ID: 19067263
    [Abstract] [Full Text] [Related]

  • 15. The behavioral toxicity of monoamine oxidase-inhibiting antidepressants.
    Murphy DL.
    Adv Pharmacol Chemother; 1977 Nov 22; 14():71-105. PubMed ID: 18913
    [No Abstract] [Full Text] [Related]

  • 16. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors.
    Kahn D, Silver JM, Opler LA.
    J Clin Psychopharmacol; 1989 Jun 22; 9(3):198-202. PubMed ID: 2738181
    [Abstract] [Full Text] [Related]

  • 17. Monoamine oxidase inhibitors revisited: what you should know.
    Goldberg JF, Thase ME.
    J Clin Psychiatry; 2013 Feb 22; 74(2):189-91. PubMed ID: 23473352
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.